Kang Stem Biotech Co. Ltd. | Income Statement
Fiscal year is January-December. All values KRW Millions.
2013
2014
2015
2016
2017
Sales/Revenue
411
208
1,485
843
9,133
Cost of Goods Sold (COGS) incl. D&A
76
50
920
384
5,868
Gross Income
335
158
565
459
3,265
SG&A Expense
3,138
4,612
5,690
9,576
14,824
EBIT
2,803
4,454
5,125
-
11,559
Unusual Expense
-
-
234
1,627
62
Non Operating Income/Expense
19
2
37
44
3,317
Interest Expense
654
1,127
948
483
1,425
Pretax Income
2,836
3,717
5,754
10,904
9,445
Income Tax
-
3
-
2,604
1,407
Consolidated Net Income
2,836
3,714
5,754
8,300
10,852
Net Income
2,836
3,714
5,754
8,300
10,225
Net Income After Extraordinaries
2,836
3,714
5,754
8,300
10,225
Net Income Available to Common
2,836
3,714
5,754
8,300
10,225
EPS (Basic)
193.29
253.63
552.53
559.13
660.96
Basic Shares Outstanding
15
15
10
15
15
EPS (Diluted)
193.50
253.41
552.47
558.95
661.30
Diluted Shares Outstanding
15
15
10
15
15
EBITDA
-
-
4,440
8,279
10,494
Non-Operating Interest Income
640
1,866
122
279
292
Minority Interest Expense
-
-
-
-
627
Equity in Affiliates (Pretax)
-
-
-
-
8
About Kang Stem Biotech Co.
View Profile
